Skip to main content
logo
Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.310
+0.030 (2.34%)
At close: May 14, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: May 14, 2026, 5:25 PM EDT

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $326.58 million as of May 14, 2026. Its market cap has increased by 186.73% in one year.

Market Cap
326.58M
Enterprise Value
283.07M
1-Year Change
186.73%
Ranking
#3470
Category
Small-Cap
Stock Price
$1.31

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $326.58M, an increase of 121.56%. That is a compound annual growth rate of 2.94%.

History

DateMarket Cap% Change
May 14, 2026326.60M-15.08%
Dec 31, 2025384.60M305.70%
Dec 31, 202494.80M-50.29%
Dec 29, 2023190.70M-4.12%
Dec 30, 2022198.90M-51.84%
Dec 31, 2021413.00M56.44%
Dec 31, 2020264.00M98.05%
Dec 31, 2019133.30M15.01%
Dec 31, 2018115.90M-57.51%
Dec 29, 2017272.80M-26.90%
Dec 30, 2016373.20M-4.09%
Dec 31, 2015389.10M25.52%
Dec 31, 2014310.00M28.15%
Dec 31, 2013241.90M51.38%
Dec 31, 2012159.80M-45.26%
Dec 30, 2011291.90M-26.38%
Dec 31, 2010396.50M181.41%
Dec 31, 2009140.90M234.68%
Dec 31, 200842.10M347.87%
Dec 31, 20079.40M54.10%
Dec 29, 20066.10M10.91%
Dec 30, 20055.50M-79.55%
Dec 31, 200426.90M43.09%
Dec 31, 200318.80M-10.05%
Dec 31, 200220.90M-60.79%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
C4 Therapeutics348.72M
Neumora Therapeutics347.11M
Greenwich LifeSciences346.36M
Rezolute344.34M
DiaMedica Therapeutics341.08M
Compass Therapeutics337.66M
Replimune Group337.31M
Immuneering336.43M
Market Cap Rankings